Antidepressant effects of exercise are produced via suppression of hypocretin/orexin and melanin-concentrating hormone in the basolateral amygdala

Neurobiology of Disease

Volumn 79, Issue , 2015, Pages 59-69

  Kim, Tae Kyung ^a,b   Kim, Ji Eun ^a   Park, Jin Young ^a   Lee, Jung Eun ^a   Choi, Juli ^a   Kim, Hannah ^a   Lee, Eun Hwa ^a   Kim, Seung Woo ^c   Lee, Ja Kyeong ^c   Kang, Hyun Sik ^b   Han, Pyung Lim ^a  

^a Ewha Womans University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Inha University School of Medicine   (South Korea)

Author keywords

BLA; Depression; Exercise; Hypocretin orexin; Melanin concentrating hormone; Stress

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; IMIPRAMINE; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR 1; OREXIN; OREXIN RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; HYPOPHYSIS HORMONE; HYPOTHALAMUS HORMONE; MELANIN; MELANIN-CONCENTRATING HORMONE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR CHANGE; BRAIN FUNCTION; BRAIN NERVE CELL; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; EXERCISE; EXPERIMENTAL SOCIAL BEHAVIOR TEST; FEMALE; FORCED SWIM TEST; GENE REPRESSION; IMMOBILITY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOCIAL INTERACTION; SUGAR INTAKE; THERAPY EFFECT; U FIELD TEST; UPREGULATION; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RUNNING;

ANIMALS; BASOLATERAL NUCLEAR COMPLEX; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; HYPOTHALAMIC HORMONES; MALE; MELANINS; MICE, INBRED C57BL; MICE, KNOCKOUT; OREXINS; PHYSICAL CONDITIONING, ANIMAL; PITUITARY HORMONES; RESTRAINT, PHYSICAL; RNA, MESSENGER; RNA, SMALL INTERFERING; RUNNING; STRESS, PSYCHOLOGICAL;

EID: 84928717736     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.04.004     Document Type: Article

References (58)

1. Allard J.S., et al. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides 2004, 38:311-315.
2. Arendt D.H., et al. Depressive behavior and activation of the orexin/hypocretin system. Behav. Neurosci. 2013, 127:86-94.
3. Borgland S.L., et al. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: emerging players in addiction. Brain Res. 2010, 1314:139-144.
4. Borowsky B., et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. 2002, 8:825-830.
5. Brundin L., et al. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur. Neuropsychopharmacol. 2007, 17:573-579.
6. Carlezon W.A., et al. The many faces of CREB. Trends Neurosci. 2005, 28:436-445.
7. Chaki S., et al. Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J. Pharmacol. Exp. Ther. 2005, 313:831-839.
8. Chemelli R.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
9. Chen X.W., et al. Hypocretin-1 potentiates NMDA receptor-mediated somatodendritic secretion from locus ceruleus neurons. J. Neurosci. 2008, 28:3202-3208.
10. Date Y., et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:748-753.
11. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Ann. N. Y. Acad. Sci. 1999, 877:614-637.
12. Duncan E.A., et al. Central administration of melanin-concentrating hormone increases alcohol and sucrose/quinine intake in rats. Alcohol. Clin. Exp. Res. 2005, 29:958-964.
13. Fritsch B., et al. Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis. Neuroscience 2009, 163:415-429.
14. Greenwood B.N., et al. 5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise. PLoS One 2012, 7. e46118.
15. Griebel G., Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?. Nat. Rev. Drug Discov. 2012, 11:462-478.
16. Guyon A., et al. Melanin-concentrating hormone producing neurons: activities and modulations. Peptides 2009, 30:2031-2039.
17. Harris G.C., et al. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
18. Hervieu G. Melanin-concentrating hormone functions in the nervous system: food intake and stress. Expert Opin. Ther. Targets 2003, 7:495-511.
19. Josefsson T., et al. Physical exercise intervention in depressive disorders: meta-analysis and systematic review. Scand. J. Med. Sci. Sports 2014, 24:259-272.
20. Kim K.S., Han P.L. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J. Neurosci. Res. 2006, 83:497-507.
21. Kim K.S., Han P.L. Mice lacking adenylyl cyclase-5 cope badly with repeated restraint stress. J. Neurosci. Res. 2009, 87:2983-2993.
22. Kim K.S., et al. Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J. Neurochem. 2008, 107:105-115.
23. Kim K.S., et al. Mice lacking adenylyl cyclase type 5 (AC5) show increased ethanol consumption and reduced ethanol sensitivity. Psychopharmacology (Berl) 2011, 215:391-398.
24. Kim T.K., et al. Physiological parameters in the blood of a murine stress-induced depression model before and after repeated passive exercise. Endocrinol. Metab. (Seoul) 2015, (in press, PMID: 25559715. [Epub ahead of print]).
25. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. Am. J. Psychiatry 2011, 167:1305-1320.
26. Krogh J., et al. The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. J. Clin. Psychiatry 2011, 72:529-538.
27. Kukkonen J.P., et al. Functions of the orexinergic/hypocretinergic system. Am. J. Physiol. Cell Physiol. 2002, 283:1567-1591.
28. Liu R.J., et al. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci. 2002, 22:9453-9464.
29. Lutter M., et al. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J. Neurosci. 2008, 28:3071-3075.
30. Madaan V., Wilson D.R. Neuropeptides: relevance in treatment of depression and anxiety disorders. Drug News Perspect. 2009, 22:319-324.
31. Martin G., et al. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul. Pept. 2002, 104:111-117.
32. McDonald A.J. Organization of amygdaloid projections to the prefrontal cortex and associated striatum in the rat. Neuroscience 1991, 44:1-14.
33. McDonald A.J. Projection neurons of the basolateral amygdala: a correlative Golgi and retrograde tract tracing study. Brain Res. Bull. 1992, 28:179-185.
34. McDonald A.J., Betette R.L. Parvalbumin-containing neurons in the rat basolateral amygdala: morphology and co-localization of calbindin-D(28k). Neuroscience 2001, 102:413-425.
35. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
36. Nocjar C., et al. The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system and of dynorphin and orexin in the hypothalamus. Neuroscience 2012, 218:138-153.
37. Nollet M., Leman S. Role of orexin in the pathophysiology of depression: potential for pharmacological intervention. CNS Drugs 2013, 27:411-422.
38. Nollet M., et al. Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression. Neuropsychopharmacology 2012, 37:2210-2221.
39. Park J.Y., et al. Implementation of a two-dimensional behavior matrix to distinguish individuals with differential depression states in a rodent model of depression. Exp. Neurobiol. 2014, 23:215-223.
40. Peyron C., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
41. Pissios P., et al. Expanding the scales: the multiple roles of MCH in regulating energy balance and other biological functions. Endocr. Rev. 2006, 27:606-620.
42. Qu D., et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380:243-247.
43. Raveendran R., et al. Phosphorylation status of the NR2B subunit of NMDA receptor regulates its interaction with calcium/calmodulin-dependent protein kinase II. J. Neurochem. 2009, 110:92-105.
44. Ressler K.J., Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat. Neurosci. 2007, 10:1116-1124.
45. Rossi M., et al. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 1997, 138:351-355.
46. Rotter A., et al. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder. J. Affect. Disord. 2011, 131:186-192.
47. Roy M., et al. A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression. Biol. Psychiatry 2007, 61:174-180.
48. Sakurai T. The role of orexin in motivated behaviours. Nat. Rev. Neurosci. 2014, 15:719-731.
49. Scott M.M., et al. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav. Brain Res. 2011, 222:289-294.
50. Seo J.S., et al. NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J. Neurosci. 2012, 32:9690-9699.
51. Sessoms-Sikes S., et al. CaMKIIalpha enhances the desensitization of NR2B- containing NMDA receptors by an autophosphorylation-dependent mechanism. Mol. Cell. Neurosci. 2005, 29:139-147.
52. Shimada M., et al. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 1998, 396:670-674.
53. Siegle G.J., et al. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol. Psychiatry 2007, 61:198-209.
54. Tsujino N., Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol. Rev. 2009, 61:162-176.
55. Tsujino N., Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front. Behav. Neurosci. 2013, 7:28.
56. Woodruff A.R., Sah P. Networks of parvalbumin-positive interneurons in the basolateral amygdala. J. Neurosci. 2007, 27:553-563.
57. Woodruff A.R., et al. GABAergic excitation in the basolateral amygdala. J. Neurosci. 2006, 26:11881-11887.
58. Yamamoto Y., et al. Interleukin-18 deficiency reduces neuropeptide gene expressions in the mouse amygdala related with behavioral change. J. Neuroimmunol. 2010, 229:129-139.